| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa791f509487f8b8f59c6545e36216fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7dcb1efbcdcf26a3cd51050ccdb8d7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbd83e0f25b773ed0ba75afe41b7a768
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e27c6d9576b561dcf238395bbf47c95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_349d253cf540a1535cf0076eda45d71b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2017-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d4d1f870ace8215462d174c1474710b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c53d520bc381a6059cf8b55d8b37f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beaf28b1bd606b145cb88fc9d8964954
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a9b938c67b6b467e26a2df447cd4715 |
| publicationDate |
2022-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11313852-B2 |
| titleOfInvention |
Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders |
| abstract |
The invention relates to compounds which activate the BASIGIN signalling pathway, preferably agonists of BASIGIN, for the treatment of neurodegenerative disorders. |
| priorityDate |
2009-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |